Antidote Strategy Private Limited
About Antidote Strategy Private Limited
Data last updated:
Antidote Strategy Private Limited is a private limited company based in Chandigarh, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 17 December 2024.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U70200CH2024PTC045998.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manik Bhandari and Neena Bhandari.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 1507 (GF), Sector 43 – B, Chandigarh, India – 160047.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.5 Lakh. For the same year it recorded a net profit of ₹37,361 (net margin 8.3%) and EBITDA of ₹50,489 (EBITDA margin 11.2%).
Company details
Contact details
Antidote Strategy Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressHouse No 1507 (GF), Sector 43 – B, Chandigarh, India – 160047
- IndustryReal Estate, Real Estate Leasing, Contractual Work
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Antidote Strategy is other service activities. In detail, this covers activities of membership organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| S | Other service activities | 94 | Activities of membership organizations |
To see the full business activity and turnover split of Antidote Strategy Private Limited, buy the company report.
Financials of Antidote Strategy Private Limited
FY 2025 filings availableAntidote Strategy Private Limited reported revenue of ₹4.5 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹50,489 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹37,361 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 11.2% |
| Net Profit Margin | 8.3% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Antidote Strategy Private Limited, buy the company report.
Board of directors of Antidote Strategy Private Limited
Antidote Strategy has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manik Bhandari | Director | 17 Dec 2024 | 1 Years 10 Months | Current |
| Neena Bhandari | Director | 17 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Antidote Strategy Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (activities of membership organizations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Slimza Foods Private Limited | ₹4.53 Lakh (FY 2025) | 155.0% | New Delhi, Delhi, India | |||
| Chaitanya Feriwale Chit Fund Private Limited | ₹4.52 Lakh (FY 2025) | 64.0% | Nanded, Maharashtra, India | |||
| Elbyte Private Limited | ₹4.52 Lakh (FY 2023) | 53.0% | Siliguri, West Bengal, India | |||
| Campaign Estate Innovation Private Limited | ₹4.51 Lakh (FY 2025) | 196.0% | Birbhum, West Bengal, India | |||
| Antidote Strategy Private Limitedthis company | ₹4.5 Lakh (FY 2025) | ₹37,361 | 8.3% | Chandigarh, India | ||
| Greenkonnect Energy Private Limited | ₹4.5 Lakh (FY 2024) | 1760.0% | Mumbai, Maharashtra, India | |||
| Sarvatra Network Private Limited | ₹4.48 Lakh (FY 2025) | -9.0% | Pune, Maharashtra, India | |||
| Mystic Guidance Private Limited | ₹4.46 Lakh (FY 2025) | Ludhiana, Punjab, India | ||||
| Ishbaran Foundation | ₹4.45 Lakh (FY 2025) | 56.0% | Nawada, Bihar, India | |||
| Sen Apartment Owners Association | ₹4.4 Lakh (FY 2025) | 28.0% | Kolkata, West Bengal, India | |||
| Computer Media Dealers' Association | ₹4.4 Lakh (FY 2024) | -23.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Antidote Strategy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Antidote Strategy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Antidote Strategy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Antidote Strategy Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Antidote Strategy Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Manik Bhandari was appointed as Director on 17 Dec 2024.
Frequently asked questions
Antidote Strategy is an active private limited company based in Chandigarh, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 17 December 2024 (2+ years old) and is registered under CIN U70200CH2024PTC045998.
Antidote Strategy has 2 current directors:
- Manik Bhandari - Director
- Neena Bhandari - Director
The latest financial statements of Antidote Strategy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Antidote Strategy is U70200CH2024PTC045998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Antidote Strategy was incorporated on 17 December 2024, making it 2+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Antidote Strategy by revenue are Slimza Foods Private Limited, Chaitanya Feriwale Chit Fund Private Limited, Elbyte Private Limited, Campaign Estate Innovation Private Limited, Greenkonnect Energy Private Limited and 5 more, all in the same principal business activity (activities of membership organizations).
Manik Bhandari was appointed as Director on 17 Dec 2024. Neena Bhandari was appointed as Director on 17 Dec 2024.
The registered office of Antidote Strategy is at House No 1507 GF, Sector 43 – B, Chandigarh, India – 160047.
Antidote Strategy operates in the real estate industry, in the real estate leasing segment.
Antidote Strategy can be reached at its registered office: House No 1507 GF, Sector 43 – B, Chandigarh, India – 160047.
Antidote Strategy is registered under the jurisdiction of the Registrar of Companies (ROC), Chandigarh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
